Source:http://linkedlifedata.com/resource/pubmed/id/11312663
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-4-23
|
pubmed:abstractText |
The purpose of this study was to determine the role of ICAM-1 in ocular herpes simplex virus type 1 (HSV-1) infection. Wild-type and ICAM-1 knockout mice were assessed for resistance to ocular HSV-1 infection in the presence of naked DNA plasmid vector or plasmid DNA encoding interferon-alpha1 topically applied to the cornea of the mice. Wild-type mice showed greater resistance to HSV-1 infection compared to ICAM-1 knockout mice as measured by cumulative survival. The absence of ICAM-1 did not affect the efficacy of the interferon-alpha1 transgene against ocular HSV-1. Both ICAM-1 and wild-type mice treated with the transgene showed a reduction in viral load and antigen expression in the trigeminal ganglion compared to the plasmid vector-treated counterparts. In contrast, the presence of the transgene reduced the number of infiltrating cells into the cornea in comparison to plasmid vector DNA controls in the wild-type mice but not in the ICAM-1 knockout mice. Collectively, these results suggest that the IFN-alpha1 transgene can restore resistance against HSV-1 infection in ICAM-1-deficient mice.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0042-6822
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2001 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
283
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
69-77
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11312663-Administration, Topical,
pubmed-meshheading:11312663-Animals,
pubmed-meshheading:11312663-Cornea,
pubmed-meshheading:11312663-Gene Therapy,
pubmed-meshheading:11312663-Herpesvirus 1, Human,
pubmed-meshheading:11312663-Intercellular Adhesion Molecule-1,
pubmed-meshheading:11312663-Interferon-alpha,
pubmed-meshheading:11312663-Keratitis, Herpetic,
pubmed-meshheading:11312663-Male,
pubmed-meshheading:11312663-Mice,
pubmed-meshheading:11312663-Mice, Inbred C57BL,
pubmed-meshheading:11312663-Mice, Knockout,
pubmed-meshheading:11312663-Plasmids,
pubmed-meshheading:11312663-Transgenes,
pubmed-meshheading:11312663-Trigeminal Ganglion,
pubmed-meshheading:11312663-Virus Replication
|
pubmed:year |
2001
|
pubmed:articleTitle |
ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-alpha1 transgene efficacy.
|
pubmed:affiliation |
Department of Ophthalmology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|